Clinical Trials Browser

Terminated × Colorectal Neoplasms × Celecoxib × Clear all

NCT05281276 2024-12-20

Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)

Phase 1 Terminated

Gastrointestinal

Colorectal Neoplasms

NCT01545141 2023-10-27

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Phase 1/2 Terminated

15 enrolled 9 charts

Gastrointestinal

Neoplasm Metastasis, Recurrence, Colorectal Neoplasms

NCT01284504 2018-03-16

Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer

Phase NA Terminated

1 enrolled 3 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00081224 2016-12-15

Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum

Phase 2 Terminated

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT00305643 2015-12-24

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Phase 3 Terminated

11 enrolled 7 charts

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

NCT00608595 2013-03-05

Celecoxib in Treating Patients With Early-Stage Rectal Cancer

Phase NA Terminated

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT00087256 2013-01-07

Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer

Phase 3 Terminated

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00037180 2008-09-29

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Phase 2 Terminated

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms